GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GliaCure Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11195
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment of Alzheimer’s disease. GliaCure offers glia-targeted medicines to treat other disorders that include traumatic brain injury, down syndrome, parkinson’s disease, glioblastoma, neuropathic pain, epilepsy, psychiatric and sleep disorders. The company builds its existing discoveries on the role of astrocytes as a critical conduit for mediating fast-acting antidepressive effects. GliaCure is headquartered in Boston, Massachusetts, the US.

GliaCure Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GliaCure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GliaCure Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
GliaCure Raises USD1.6 Million in Venture Financing 10
GliaCure Raises USD5.8 Million in Series B Financing 11
GliaCure Raises USD3 Million in Venture Financing 12
Gliacure Raises Additional US$1.8 Million In Venture Financing 13
Licensing Agreements 14
GliaCure Enters into Licensing Agreement with Tufts University 14
GliaCure Inc – Key Competitors 15
GliaCure Inc – Key Employees 16
GliaCure Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
GliaCure Inc, Pharmaceuticals & Healthcare, Key Facts 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Deals By Therapy Area, 2012 to YTD 2018 8
GliaCure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GliaCure Raises USD1.6 Million in Venture Financing 10
GliaCure Raises USD5.8 Million in Series B Financing 11
GliaCure Raises USD3 Million in Venture Financing 12
Gliacure Raises Additional US$1.8 Million In Venture Financing 13
GliaCure Enters into Licensing Agreement with Tufts University 14
GliaCure Inc, Key Competitors 15
GliaCure Inc, Key Employees 16

List of Figures
GliaCure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeoGenomics Inc (NEO):医療機器:M&Aディール及び事業提携情報
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Aegean Marine Petroleum Network Inc (ANW):石油・ガス:M&Aディール及び事業提携情報
    Summary Aegean Marine Petroleum Network Inc (AMPL) is a provider of marine fuel logistics services. The company markets and offers refined marine fuels and lubricants to ships. Its lubricants include marine fuels, mineral, cargo trading, marine lubricants, synthetic and next generation bio degradabl …
  • Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. O …
  • Slovnaft AS (1SLN01AE):企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • AB Sciex LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary AB Sciex LLC (Sciex), a subsidiary of Danaher Corp, is a provider of life science analytical technologies. The company provides mass spectrometry solutions combined with capillary electrophoresis and liquid chromatography. Its product portfolio includes liquid chromatography-mass spectromete …
  • Mexco Energy Corp:企業の財務・戦略的SWOT分析
    Summary Mexco Energy Corp (Mexco Energy) is an oil and gas company that offers exploration, acquisition, production, and development of crude oil, natural gas, condensate liquids, and natural gas liquids. The company acquires producing and non-producing oil and gas leases from landowners and leaseho …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Siemens Healthcare GmbH-医療機器分野:企業M&A・提携分析
    Summary Siemens Healthcare GmbH d/b/a Siemens Healthineers, a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT and medical infrastructure …
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Trafigura Beheer BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Trafigura Beheer BV (Trafigura Beheer) is an independent commodity trading and logistics company. The company’s investments portfolio includes crude and petroleum products, non-ferrous concentrates, refined metals and bulk commodities, and shipping and chartering. Its oil and petroleum produ …
  • Warrnambool Cheese and Butter Factory Company Holdings Limited:企業の戦略・SWOT・財務情報
    Warrnambool Cheese and Butter Factory Company Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Warrnambool Cheese and Butter Factory Company Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report cov …
  • Patrys Ltd (PAB)-製薬・医療分野:企業M&A・提携分析
    Summary Patrys Ltd (Patrys) is a healthcare company that provides therapeutic products. The company offers product pipeline such as PAT-SC1 used for the treatment of gastric cancer; PAT-SM6, PAT-PA1, and PAT-LM1 used to treat multiple cancers. It develops natural human antibody-based therapeutic pro …
  • Akcea Therapeutics Inc (AKCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Akcea Therapeutics Inc (Akcea Therapeutics), a subsidiary of Ionis Pharmaceuticals Inc, is a developer and commercializer of drugs to treat patients with cardiometabolic diseases caused by lipid disorders. The company’s drugs are designed based on advanced antisense technology. Its pipeline …
  • Tessco Technologies Incorporated (TESS):企業の財務・戦略的SWOT分析
    Tessco Technologies Incorporated (TESS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Lannett Co Inc (LCI):企業の財務・戦略的SWOT分析
    Lannett Co Inc (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Carbon Energy Corp (CRBO):石油・ガス:M&Aディール及び事業提携情報
    Summary Carbon Energy Corp (Carbon Energy), formerly Carbon Natural Gas Company is an independent oil and gas company. The company operates in the exploration, operation, management, and development of oil and gas properties in the Appalachian and Illinois Basin regions of the US. It holds interests …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. Nippon Chemiphar offers diagnostic products, such as IgE NC, a diagnostic kit t …
  • GE Global Research-医療機器分野:企業M&A・提携分析
    Summary GE Global Research (GE Global), a subsidiary of General Electric Company is a research and development company that develops technologies for various industry sectors. The company offers diverse technologies which are used in electronics, chemistry, biosciences, computing, metallurgy, fluid …
  • The Walsh Group:企業の戦略・SWOT・財務分析
    The Walsh Group - Strategy, SWOT and Corporate Finance Report Summary The Walsh Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Agthia Group PJSC:企業の戦略・SWOT・財務情報
    Agthia Group PJSC - Strategy, SWOT and Corporate Finance Report Summary Agthia Group PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆